Evidence map›Paper›PMID 31650455›Full record

ReviewJournal of assisted reproduction and genetics2019

Revisiting debates of premature luteinization and its effect on assisted reproductive technology outcome.

Reda S Hussein, Ihab Elnashar, Ahmed F Amin, Hisham A Abou-Taleb, Ahmed M Abbas, Ahmed M Abdelmageed, Tarek Farghaly, Yulian Zhao

Open access · greenAbstract readReview
In one paragraph

Review in Journal of assisted reproduction and genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Reda S HusseinDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Ihab ElnasharDepartment of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Ahmed F AminDepartment of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Hisham A Abou-TalebDepartment of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Ahmed M AbbasDepartment of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt. ans1111eg@gmail.com.ORCID http://orcid.org/0000-0002-2359-2729
Ahmed M AbdelmageedDepartment of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Tarek FarghalyDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Yulian ZhaoDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Assiut University · EGMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of the prematurely elevated serum progesterone on the late follicular phase, commonly known as premature luteinization (PL), is a matter of continuing debate. Available evidence supports that serum progesterone ≥ 1.5 ng/ml on the day of ovulation triggering could reduce the pregnancy potential in fresh in vitro fertilization (IVF) cycles by jeopardizing endometrial receptivity. Causes of PL during ovarian stimulation are unclear. Recent studies point toward the daily follicle-stimulating hormone dosage, duration of controlled ovarian stimulation, number of oocytes retrieved, and peak estradiol level as factors affecting the incidence of PL. Emerging data show additional influence on embryo quality. The prevention of PL has been challenging. The key elements in preventing PL include individualization of ovarian stimulation according to patient's ovarian reserve, proper ovulation trigger timing, and use of medications such as corticosteroids and metformin. Embryo cryopreservation with deferred embryo transfer is the established strategy to overcome PL, yet it is an extra burden to the IVF laboratory and increased cost for patients. Herein, we review the up-to-date knowledge of this frequent IVF problem including causes, proposed diagnostic criteria, and its impact on endometrial receptivity, embryo quality, and pregnancy outcomes. The preventive measures and rescue strategies are also discussed.

Indexed as

FemaleFertilization in VitroHumansLuteinizationOvaryOvulationOvulation InductionPregnancyPregnancy OutcomeReproductive Techniques, AssistedARTDiagnosis of PLPremature luteinizationPrevention of PLProgesterone elevation

Identifiers

PMID31650455
PMCPMC6885458
OpenAlexW2981708189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.